ArticleClinical cancer research : an official journal of the American Association for Cancer Research2014

A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in patients with metastatic colorectal cancer treated with salvage cetuximab/panitumumab monotherapy.

Zenia Saridaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.